Ameriprise Portfolio holdings
Ameriprise Financial, Inc., founded in 1894 as Investors Syndicate and headquartered in Minneapolis, Minnesota, is a leading financial services firm specializing in wealth management, financial planning, and insurance, managing hundreds of billions in assets for individual and institutional clients. Evolving from its roots in investment certificates, it now offers a comprehensive suite of services, including retirement planning, annuities, mutual funds, and advisory solutions, delivered through a network of over 10,000 financial advisors across the U.S. Known for its client-first approach, Ameriprise became independent in 2005 after spinning off from American Express, focusing on personalized advice and robust digital tools to compete in a crowded market. With a strong emphasis on long-term relationships and financial security, Ameriprise has grown into a trusted name in the retail investment and insurance sectors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR Bloomberg 1-3 Month T-Bill ETF
BIL
|
+$760M |
| 2 |
Alphabet (Google) Class A
GOOGL
|
+$430M |
| 3 |
NVIDIA
NVDA
|
+$287M |
| 4 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$268M |
| 5 |
XYZ
Block Inc
XYZ
|
+$266M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ESRX
Express Scripts Holding Company
ESRX
|
+$475M |
| 2 |
Pfizer
PFE
|
+$356M |
| 3 |
iShares Core S&P 500 ETF
IVV
|
+$325M |
| 4 |
Apple
AAPL
|
+$325M |
| 5 |
Microsoft
MSFT
|
+$323M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17% |
| 2 | Financials | 12.96% |
| 3 | Healthcare | 12.18% |
| 4 | Consumer Discretionary | 8.39% |
| 5 | Industrials | 7.92% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
CLVS
2926
DELISTED
Clovis Oncology, Inc.
CLVS
| $896K | ﹤0.01% |
49,960
-41,313
| -45% | -$844K |
|
2927
Geospace Technologies
GEOS
$69.2M
| $893K | ﹤0.01% |
86,583
-1,405
| -2% | -$18.8K |
|
|
CMTA
2928
DELISTED
Clementia Pharmaceuticals Inc.
CMTA
| $891K | ﹤0.01% |
+75,734
| New | +$942K |
|
2929
United Parks & Resorts
PRKS
$2B
| $890K | ﹤0.01% |
40,267
-13,777
| -25% | -$368K |
|
2930
iShares Agency Bond ETF
AGZ
$564M
| $883K | ﹤0.01% |
7,875
+5,351
| +212% | +$592K |
|
2931
Aldeyra Therapeutics
ALDX
$91.1M
| $879K | ﹤0.01% |
105,967
+23,085
| +28% | +$237K |
|
|
PLYA
2932
DELISTED
Playa Hotels & Resorts
PLYA
| $878K | ﹤0.01% |
122,110
| – | – |
|
2933
Barnes & Noble Education
BNED
$435M
| $877K | ﹤0.01% |
2,186
+144
| +7% | +$80.2K |
|
|
TCDA
2934
DELISTED
Tricida, Inc. Common Stock
TCDA
| $875K | ﹤0.01% |
+37,108
| New | +$1.07M |
|
2935
State Street SPDR Portfolio Short Term Treasury ETF
SPTS
$6.11B
| $873K | ﹤0.01% |
29,528
-12,400
| -30% | -$365K |
|
2936
BlackRock Floating Rate Income Strategies Fund
FRA
$391M
| $872K | ﹤0.01% |
73,297
-108,214
| -60% | -$1.39M |
|
2937
Nuveen Preferred & Income Opportunities Fund
JPC
$2.91B
| $872K | ﹤0.01% |
104,594
-12,892
| -11% | -$114K |
|
2938
Melco Resorts & Entertainment
MLCO
$2.16B
| $870K | ﹤0.01% |
49,302
-1,410,643
| -97% | -$25.1M |
|
|
MHN
2939
DELISTED
BlackRock MuniHoldings New Yrok Quality Fund
MHN
| $869K | ﹤0.01% |
72,547
+18,094
| +33% | +$214K |
|
2940
BlackRock Limited Duration Income Trust
BLW
$493M
| $867K | ﹤0.01% |
64,913
+1,939
| +3% | +$27.5K |
|
2941
Otter Tail
OTTR
$3.96B
| $867K | ﹤0.01% |
17,446
+9,692
| +125% | +$463K |
|
2942
CALL
Macerich
MAC
$6.96B
| $866K | ﹤0.01% |
+20,000
| New | +$989K |
|
2943
SK Telecom
SKM
$12.9B
| $864K | ﹤0.01% |
19,552
-970
| -5% | -$43.1K |
|
2944
CNA Financial
CNA
$13.8B
| $863K | ﹤0.01% |
19,585
-9,589
| -33% | -$432K |
|
2945
Anterix
ATEX
$1.81B
| $862K | ﹤0.01% |
+23,055
| New | +$901K |
|
2946
Pacific Biosciences
PACB
$354M
| $862K | ﹤0.01% |
116,322
+103,330
| +795% | +$655K |
|
2947
AngloGold Ashanti
AU
$49.3B
| $857K | ﹤0.01% |
68,309
+13,393
| +24% | +$137K |
|
2948
Nuveen Municipal Credit Income Fund
NZF
$2.42B
| $854K | ﹤0.01% |
63,657
-30,082
| -32% | -$408K |
|
2949
First Bancorp
FBNC
$2.7B
| $851K | ﹤0.01% |
26,042
-26,270
| -50% | -$981K |
|
2950
Compass Diversified
CODI
$927M
| $845K | ﹤0.01% |
67,941
+3,793
| +6% | +$58.4K |
|
Similar funds
Ameriprise's Q4 2018 Portfolio in Review
As of Q4 2018, Ameriprise held 3,899 positions worth $200B, down 30% from $286B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Ameriprise's Q4 2018 filing shows 170 new, 1,630 increased, 1,715 reduced and 248 closed positions. Its largest new stake was Linde: 460,065 shares worth $71.8M. The largest sale was Express Scripts Holding Company, an estimated $475M.
By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 16% a quarter earlier, followed by Financials and Healthcare.
- Ameriprise's largest Q4 2018 buy was Linde: 460,065 shares worth $71.8M.
- Ameriprise added most to State Street SPDR Bloomberg 1-3 Month T-Bill ETF in Q4 2018, an estimated $760M increase.
- Ameriprise's biggest Q4 2018 reduction was Pfizer, cutting an estimated $356M.
- Ameriprise fully exited Express Scripts Holding Company in Q4 2018, selling an estimated $475M.
- Ameriprise's ten largest holdings make up 14% of its $200B portfolio in Q4 2018.
- Ameriprise opened 170 new positions and closed 248 in Q4 2018.
- Ameriprise's portfolio value fell 30% quarter-over-quarter to $200B.
Based on Ameriprise's 13F filing for Q4 2018, filed 14 Feb 2019.